Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index-Reference-Cited by-同舟云学术

Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index

Published:2021-01 Issue: Volume:142 Page:18-28
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Buti Sebastiano^ORCID,Bersanelli Melissa^ORCID,Perrone Fabiana^ORCID,Tiseo Marcello^ORCID,Tucci Marco,Adamo Vincenzo,Stucci Luigia S.,Russo Alessandro^ORCID,Tanda Enrica T.^ORCID,Spagnolo Francesco^ORCID,Rastelli Francesca,Pergolesi Federica,Santini Daniele,Russano Marco^ORCID,Anesi Cecilia,Giusti Raffaele,Filetti Marco,Marchetti Paolo,Botticelli Andrea,Gelibter Alain,Occhipinti Mario Alberto,Ferrari Marco,Vitale Maria Giuseppa,Nicolardi Linda,Chiari Rita^ORCID,Rijavec Erika,Nigro Olga^ORCID,Tuzi Alessandro,De Tursi Michele,Di Marino Pietro,Conforti Fabio,Queirolo Paola,Bracarda Sergio,Macrini Serena,Gori Stefania,Zoratto Federica,Veltri Enzo,Di Cocco Barbara,Mallardo Domenico^ORCID,Vitale Maria Grazia,Santoni Matteo,Patruno Leonardo,Porzio Giampiero,Ficorella Corrado,Pinato David J.,Ascierto Paolo A.,Cortellini Alessio^ORCID

Funder

Welcome Trust Strategic Fund

NIHR Imperial Biomedical Research Centre

Cancer Research UK

Imperial Experimental Cancer Medicine Centre

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference42 articles.

1. Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association?;Hussain;Hum Vaccines Immunother,2020

2. The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy;Gopalakrishnan;Canc Cell,2018